Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CHRM2 Stable Cell Line

    [CAT#: S01YF-0923-PY128]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX635 Magic™ Rat CHRM2 in Vitro Calcium Flux Assay Rat CHO-K1-Gα16 Calcium Flux Assay

    Product Information

    Target Protein
    CHRM2
    Target Family
    Muscarinic Acetylcholine Family
    Target Protein Species
    Human
    Host Cell Type
    U87MG;A172;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    CNS Research;Pain and Addiction Research
    Related Diseases
    Depressive Disorder;Drug Dependence
    Gene ID
    Human: 1129
    UniProt ID
    Human: P08172

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CHRM2, encoding the muscarinic acetylcholine receptor M2, has been extensively studied for its role in various physiological processes. In the context of cancer, CHRM2 has been identified as a potential prognostic marker in hepatocellular carcinoma, with its involvement in essential tumor-promoting pathways. Furthermore, variations in CHRM2 have been associated with tardive dyskinesia in schizophrenia, suggesting its potential role in neuropsychiatric disorders. The receptor's involvement in cognitive operations also underscores its significance in neurological research.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CHRM2 Stable Cell Line (S01YF-0923-PY128). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Rebecca (Verified Customer)

    How is CHRM2 associated with tardive dyskinesia in schizophrenia patients? Aug 13 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Variations in the CHRM2 gene have been associated with tardive dyskinesia in schizophrenia, although the association may be influenced by other concomitant factors. Aug 13 2020

    chat Cynthia (Verified Customer)

    What role does CHRM2 play in the transition from acute to chronic neuropathic pain? Jan 02 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CHRM2 is involved in the acute-to-chronic neuropathic pain transition, with REST up-regulation in DRG neurons playing a crucial role in the transcriptional repression of CHRM2 in neuropathic pain. Jan 02 2022

    Published Data

    Fig.1 Quantitative PCR revealed that CHRM2 and miR-490-3p were downregulated in the GBM cell lines U87MG and A172.

    In two GBM cell lines, namely U87MG and A172, CHRM2 and miR-490-3p expression levels were assessed through qRT-PCR analysis. It was evident that both CHRM2 and miR-490-3p exhibited significant downregulation. For normalization of miRNA and mRNA data, RNU6B (U6) and GAPDH were utilized as controls. The data were processed using the 2−ΔΔCt method, and the graphical representation reflects the mean ± SD derived from a minimum of three independent experiments (*p < 0.05, **p < 0.01).

    Ref: Vinchure, Omkar S., et al. "Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas." International journal of cancer 145.5 (2019): 1254-1269.

    Pubmed: 31008529

    DOI: 10.1002/ijc.32360

    Research Highlights

    Tegegne BS, et al. "Phenotypic but not genetically predicted heart rate variability associated with ." Communications biology, 2023.
    The link between low heart rate variability (HRV) and mortality has been well documented. However, the specific molecular mechanisms behind this association remain unclear. To address this gap, a study was conducted to identify new genetic variations associated with HRV and investigate their relationship with mortality. Using data from the UK Biobank, 46,075 individuals of European ancestry were included in a genome-wide association study. The study identified 17 genetic variants in 16 loci that were significantly associated with HRV traits. Interestingly, eight of these loci (RNF220, GNB4, LINCR-002, KLHL3/HNRNPA0, CHRM2, KCNJ5, MED13L, and C160rf72) have not been previously reported. A follow-up analysis examining the relationship between HRV and mortality over a median follow-up of seven years found that individuals with lower HRV were at a higher risk of death from any cause. However, genetically predicted HRV, as determined by genetic risk scores, was not found to be associated with mortality. These results provide important insights into the underlying biological mechanisms of HRV and highlight the significance of the cardiac autonomic nervous system in predicting mortality.
    Pubmed: 37803156   DOI: 10.1038/s42003-023-05376-y

    Zeng H, et al. "Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine ." Journal of neuroinflammation, 2023.
    Spinal cord injury (SCI) is a devastating central nervous system disease that results in loss of sensory and motor function below the level of injury. A common secondary effect of SCI is SCI-induced immunodeficiency syndrome (SCI-IDS), which increases the risk of infection and worsens neurological dysfunction. Previous studies have shown that SCI-IDS is an independent risk factor for poor neurological outcomes, particularly in cases of injury above the T5 levels. While the mechanism behind SCI-IDS is unclear, research utilizing experimental rats has revealed changes in neuroendocrine-immune regulation following SCI. Atrophy of secondary immune organs and elevated cortisol levels suggest impaired immune function and autonomic disturbance. A differential gene regulation analysis showed disrupted inflammatory and circadian rhythm pathways, potentially contributing to a systemic suppression of peripheral adaptive immunity. Ultimately, SCI-induced neuroinflammation impedes nerve repair and increases susceptibility to infection, leading to poor neurological prognosis.
    Pubmed: 37775760   DOI: 10.1186/s12974-023-02906-7

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare